Arcus Biosciences Earnings
NYSE: RCUSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Tue, Oct 27, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.93
Arcus Biosciences earnings summary
Arcus Biosciences is scheduled to report Sep/2026 earnings on Oct 27, 2026, with analysts expecting EPS of $-0.93. In its most recent report on Aug 5, 2026 (Q2 2026), RCUS posted EPS of $-0.72. Revenue for the quarter was $41.0 million.
Across the last 16 reports, RCUS shares moved an average of 6.6% (in either direction) in the first trading session after results, rising 8 times and falling 8 times.
Summary generated from market data by MetaCap's automated system. Methodology
RCUS earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 5, 2026 | — | $-0.72 | — | +3.0% |
| May 5, 2026 | — | $-1.02 | — | -6.2% |
| Feb 25, 2026 | — | $-0.88 | — | +8.5% |
| Oct 28, 2025 | — | $-1.27 | — | -2.1% |
| Aug 6, 2025 | — | $0.00 | — | +14.7% |
| May 6, 2025 | — | $-1.14 | — | +3.4% |
| Feb 25, 2025 | — | $-1.07 | — | -12.0% |
| Nov 6, 2024 | — | $-1.00 | — | -12.0% |
| Aug 8, 2024 | — | $-1.02 | — | -0.1% |
| May 8, 2024 | — | $-0.05 | — | +1.1% |
| Feb 21, 2024 | — | $-1.08 | — | -2.2% |
| Nov 7, 2023 | — | $-0.94 | — | +7.0% |
| Aug 7, 2023 | — | $-1.04 | — | +4.6% |
| May 9, 2023 | — | $-1.09 | — | -1.1% |
| Feb 28, 2023 | — | $-0.92 | — | -9.3% |
| Nov 2, 2022 | — | $-0.90 | — | +18.9% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.